CGBIO (CEO Hyun-seung Yu), a specialist in bio-regenerative medicine, announced on the 10th that it participated in the ‘Florida International Medical Expo (FIME) 2024’ held recently at the Miami Beach Convention Center in Florida, USA, accelerating its penetration into the Latin American medical device market.
FIME 2024 is North America’s largest medical exhibition targeting medical device and medical supply buyers in Latin America. Leveraging the geographical advantage of Miami, the host city, it attracts participants from 50 countries, not only from North America but also from Latin America, with a total visitor count reaching 50,000. Currently, the Latin American medical market is experiencing steady growth in demand for medical devices and supplies due to strengthened welfare policies, improved healthcare systems, and population aging trends, making it a focal point for global market expansion opportunities.
CGBIO participated in this exhibition to discover local contract opportunities for surgical and Negative Pressure Wound Therapy (NPWT) products and expand new networking possibilities. At FIME 2024, CGBIO operated a booth actively promoting its representative medical device product lines including ▲CURASYS2 & CURAVAC ▲NOVOSIS ▲NOVOMAX ▲EXCENDER ▲Bongener ▲Mediclore ▲Excelos Inject ▲ALLOBONE. Through this, the company took the opportunity to widely showcase the excellence of its products and explore new contract opportunities.
CGBIO focused on discovering new partner companies by conducting business meetings with over 150 companies. Additionally, the company discussed the progress of medical device approvals with existing distributors and connected new medical professionals with distributors, striving to increase sales through existing distribution channels. The company also continued active networking by sharing in-depth feedback on its products with local suppliers and surgeons.
Innosys, which operated a joint booth, introduced ▲Anax 5.5, a spinal implant for thoracic and lumbar interbody fixation ▲Velofix SA, a cervical cage ▲Aspiron, an anterior metal plate for cervical fixation ▲L’DISQ, the world’s first spinal pain treatment device with directional control using microelectrodes ▲Innoverse screw, a spinal fixation screw scheduled for release within the year.
Hyun-seung Yu, CEO of CGBIO, stated, “FIME 2024 served as a crucial stepping stone for expanding our presence in the Latin American market with CGBIO’s unique regenerative medicine solutions. In line with the increasing demand for medical devices in the Latin American market, we will continue to showcase our innovative medical device products and build unrivaled competitiveness in the global market.”
▲ Visitors at the CGBIO booth at FIME 2024
